Wan-zhong Wang

发表

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

S. Ren, Caicun Zhou, G. Gao, 2021, Translational lung cancer research.

The levels of urine CTX-II, C2C, and PYD in children patients with Kashin-Beck disease in Qinghai Province of China

Liyan Sun, Xianhao Wu, Wan-zhong Wang, 2019, Journal of Orthopaedic Surgery and Research.

CMAR_A_302545 3981..3990

S. Ren, Caicun Zhou, Xiaofei Yu, 2021 .

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations

S. Ren, Caicun Zhou, G. Gao, 2021, Translational lung cancer research.

Special issue “The advance of solid tumor research in China”: FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer

T. Jiang, S. Ren, Caicun Zhou, 2022, International Journal of Cancer.

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer

S. Ren, Caicun Zhou, Chunyan Wu, 2021, Cancer management and research.

ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC

S. Ren, Caicun Zhou, G. Gao, 2021, Cancer Immunology, Immunotherapy.

Current status and future perspectives of bispecific antibodies in the treatment of lung cancer

S. Ren, Wan-zhong Wang, Tianyu Qiu, 2023, Chinese medical journal.

Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion.

S. Ren, Caicun Zhou, G. Gao, 2023, Lung cancer.

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation

S. Ren, Caicun Zhou, G. Gao, 2023, Chinese medical journal.